TABLE 3.
Univariate Analysis | Local Control | LFS | Distant Metastasis | Overall Survival | ||||
---|---|---|---|---|---|---|---|---|
|
||||||||
HR (95% CI) | p Value | HR (95% CI) | p Value | HR (95% CI) | p Value | HR (95% CI) | p Value | |
IMRT vs Conventional | 0.96 (0.38-2.47) | 0.938 | 1.39 (0.73-2.65) | 0.318 | 2.47 (0.48-12.65) | 0.278 | 1.85 (0.89-3.86) | .100 |
T2 vs. T1 stage | 2.38 (1.26-4.49) | 0.008 | 1.81 (1.16-2.83) | 0.009 | 3.57 (0.88-14.40) | 0.076 | 1.37 (0.83-2.25) | .215 |
Age | 1.00 (0.97-1.02) | 0.874 | 1.04 (1.01-1.05) | <0.001 | 1.07 (0.99-1.14) | 0.068 | 1.07 (1.04-1.09) | <.001 |
Smoking (yes vs no) | 0.45 (0.22-0.91) | 0.027 | 1.19 (0.64-2.22) | 0.583 | 0.48 (0.10-2.37) | 0.365 | 1.80 (0.83-3.92) | .138 |
Gender (Male vs female) | 1.18 (0.46-3.01) | 0.729 | 1.14 (0.65-2.00) | 0.649 | 0.51 (0.10-2.54) | 0.409 | 1.01 (0.55-1.86) | .977 |
Fractionation (2.25 vs 2 Gy) | 1.03 (0.54-1.96) | 0.925 | 1.077 (0.684-1.696) | 0.748 | 1.32 (0.30-5.77) | 0.710 | 1.31 (0.78-2.22) | .312 |
Total dose | 1.00 (0.999-1.001) | 0.796 | 1.00 (1.000-1.001) | 0.690 | 1.00 (0.998-1.004) | 0.377 | 1.00 (0.999-1.001) | .836 |
Year of treatment | 1.00 (0.95-1.06) | 0.973 | 1.01 (0.97-1.05) | 0.720 | 1.08 (0.93-1.26) | 0.291 | 1.01 (0.97-1.06) | .605 |
Abbreviations: CI, confidence interval; HR, hazard ratio.